“Biochip development continued during the Quarter with a biosensing graphene transistor
design sent to a commercial foundry to make the devices on a multi-project wafer. The goal is
to optimise the design and then select the design that works the best and can be easily scaled
up for commercial production. By the end of 2023, the Company should receive the first batch
of chips from the foundry.”
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $68.80M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.5¢ | 26.5¢ | $39.48K | 146.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 71996 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 77572 | 1 |
View Market Depth
| Last trade - 15.37pm 17/06/2025 (20 minute delay) ? |
| AXE (ASX) Chart |